selegiline

(redirected from Anipryl)
Also found in: Medical.

se·leg·i·line

 (sə-lĕj′ə-lēn′)
n.
A selective monoamine oxidase inhibitor, C13H17N, used transdermally as an antidepressant and in its hydrochloride form in conjunction with levodopa and carbidopa to treat patients with Parkinson's disease.

[Probably sele(ctive) (from its being a selective monoamine oxidase inhibitor) + alteration of (par)gyline, a closely related drug (ultimately from Latin arg(entum), silver; see arg- in Indo-European roots from the fact that one of the constituents of pargyline was discovered in a precipitate containing silver + -yl + -ine).]

selegiline

(səˈlɛɡɪˌliːn)
n
(Medicine) a drug used in treating Parkinson's disease, depression and dementia
Translations

selegiline

n selegilina
References in periodicals archive ?
The drug Anipryl was approved by the FDA as a treatment for canine cognitive dysfunction and is sometimes effective for dogs, but it hasn't been approved for feline use.
Potential Treatments: Mitotane, ketoconazole, adrenalectomy, Anipryl, and radiation therapy of pituitary.
Anipryl is approved for the treatment of canine age-related cognitive disorder, and Clomipramine is approved for the treatment of separation anxiety.
This falling out began in 1998 when DAHI's parent company announced that the FDA had approved the drug Anipryl when used to treat canine cognitive dysfunction.
Made by Pfizer, Anipryl has worked (to some extent) in about 75% of dogs with this problem.
Also on January 5 the FDA gave the thumbs up to Pfizer's Anipryl, the first drug approved for doggie Alzheimer's.
Anipryl by Pfizer, taken daily, helps reorient older dogs diagnosed with Cognituve Dysfunction Syndrome, characterized by disorientation or confusion, not recognizing owners, sleep disorders and house-training problems.
Do not combine DLPA with MAOI drugs like Anipryl, used to treat Cushing's Disease and canine cognitive dysfunction, or amitraz, an ingredient in tick collars.
Veterinarians may prescribe Anipryl (selegiline), the first FDA-approved drug to control the signs of signs of canine CDS.
For example, products containing amitraz (such as Certifect) should not be used on "medicated" dogs, such as those with diabetes or heart problems; amitraz, a monoamine oxidase inhibitor (MAOI), can be dangerous when combined with antidepressants (such as those used to treat separation anxiety), Anipryl (used for canine cognitive dysfunction and Cushing's disease), and DL-Phenylalanine (DLPA), used to treat chronic pain.